Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Arthritis Research & Therapy|February 11, 2026
Establishing C-X-C motif chemokine receptor 4 as a novel imaging target in giant cell arteritisMatthias Fröhlich, Sebastian E Serfling, Michael Gernert, et al.
Frontiers in Immunology|November 8, 2024
Psychological impact of autologous hematopoietic stem cell transplantation in systemic sclerosis patients and influence of resilienceMarc Schmalzing, Michael Gernert, Matthias Fröhlich, et al.
Rheumatology (Oxford, England)|February 2, 2024
MRVAS-introducing a standardized magnetic resonance scoring system for assessing the extent of inflammatory burden in giant cell arteritisMatthias Froehlich, Konstanze V Guggenberger, Marius Vogt, et al.
Frontiers in Immunology|April 3, 2026
[18F]-FDG-PET/CT detects subclinical optic nerve inflammation in giant cell arteritisMichael Gernert, Marc Schmalzing, Matthias Fröhlich, et al.
Frontiers in Immunology|October 30, 2020
Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot StudyQuirin Notz, Marc Schmalzing, Florian Wedekink, et al.
Rheumatology International|April 29, 2024
The exercise-app Axia for axial spondyloarthritis enhances the home-based exercise frequency in axial spondyloarthritis patients - A cross-sectional surveyPatrick-Pascal Strunz, Maxime Le Maire, Tobias Heusinger, et al.
Annals of the Rheumatic Diseases|March 13, 2026
An app-based nonpharmacological intervention improves patient-reported disease activity, functionality, and quality of life in patients with axial spondyloarthritis: a randomised controlled trialPatrick-Pascal Strunz, Matthias Froehlich, Tobias Heusinger, et al.
Rheumatology International|April 15, 2025
Janus kinase inhibitors show a longer drug survival than biologics in a real-world cohort of patients with rheumatoid arthritis - a retrospective analysis from the RHADAR databaseLinus Maximilian Risser, Torsten Witte, Matthias Englbrecht, et al.
Zeitschrift Fur Rheumatologie|September 23, 2025
[Renewed increase in new Janus kinase inhibitor prescriptions : Analysis of the German RHADAR registry]Patrick-Pascal Strunz, Linus Maximilian Risser, Matthias Englbrecht, et al.
Frontiers in Immunology|September 6, 2024
Use of Janus kinase inhibitors before and after European Medicines Agency safety recommendations: a retrospective studyPatrick-Pascal Strunz, Linus Maximilian Risser, Matthias Englbrecht, et al.
Pageof 5